Growth Metrics

Enanta Pharmaceuticals (ENTA) Shareholder's Equity (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -7.90%
Dec 31, 2025 95.61%
Sep 30, 2025 -18.37%
Jun 30, 2025 -15.24%
Mar 31, 2025 -16.35%
Dec 31, 2024 -13.20%
Sep 30, 2024 -13.50%
Jun 30, 2024 -10.35%
Mar 31, 2024 -13.43%
Dec 31, 2023 -11.47%
Sep 30, 2023 -8.87%
Jun 30, 2023 -11.71%
Mar 31, 2023 -10.46%
Dec 31, 2022 -6.38%
Sep 30, 2022 -4.94%
Jun 30, 2022 -5.73%
Mar 31, 2022 -6.71%
Dec 31, 2021 -3.77%
Sep 30, 2021 -4.41%
Jun 30, 2021 -4.17%
Mar 31, 2021 -3.53%
Dec 31, 2020 -0.79%
Sep 30, 2020 -5.20%
Jun 30, 2020 -1.12%
Mar 31, 2020 0.77%
Dec 31, 2019 4.28%
Sep 30, 2019 3.21%
Jun 30, 2019 2.73%
Mar 31, 2019 2.20%
Dec 31, 2018 8.42%
Sep 30, 2018 9.08%
Jun 30, 2018 8.25%
Mar 31, 2018 4.98%
Dec 31, 2017 5.27%
Sep 30, 2017 15.64%
Jun 30, 2017 -1.93%
Mar 31, 2017 -0.80%
Dec 31, 2016 -0.65%
Sep 30, 2016 0.35%
Jun 30, 2016 0.97%
Mar 31, 2016 0.81%
Dec 31, 2015 11.91%
Sep 30, 2015 3.45%
Jun 30, 2015 1.81%
Mar 31, 2015 15.75%
Dec 31, 2014 30.31%
Sep 30, 2014 -2.81%
Jun 30, 2014 50.37%
Mar 31, 2014 -3.66%
Dec 31, 2013 -4.42%
Sep 30, 2013 -3.45%
Jun 30, 2013 -3.35%